The BalancedInvestor Club

ADVB Market Analysis

Overview

Fundamentals

P/E ratio1.50
EPS (TTM)$3.520.0% YoY
Profit margin0.0%HEALTHCARE
Market cap$7.2MMicro cap

Valuation

Forward P/E
—
PEG ratio
—
P/B
0.76
P/S (TTM)
—
EV/EBITDA
—

Profitability & growth

ROE (TTM)
80.2%
Operating margin
0.0%
Revenue growth YoY
0.0%
Dividend yield
—
Beta
—
Last earnings
Dec 31, 2025 · Reported $0.20
Analyst estimate. Actual results often differ.

Ratios are point-in-time. Historical metrics — no guarantees about what comes next.

News & Sentiment

Page 1 of 3 · 50 total

Via 3rd party. Not a recommendation or advice by The Balanced Investor Club. See disclaimer.

About Advanced Biomed Inc. Common Stock

Advanced Biomed Inc., an investment holding company, engages in the research and development of microfluidic biochip technologies and provides them for precision oncology detection, diagnosis, and treatment in Taiwan. The company is headquartered in New York, New York.

Classification

Sector
Healthcare
Industry
Diagnostics & Research
Exchange
NASDAQ
Country
USA
Currency
USD

Company profile

HQ
122 EAST 42ND STREET, NEW YORK, NY
Fiscal year end
June
Latest quarter
Dec 31, 2025
Market cap$7.2M
Shares outstanding$1.4M
52W high$48.80
52W low$3.61

Educational content · Not investment advice or recommendations

We're educators, not advisors. Your decisions are your own. Disclaimer